Description

Session ID: 1828

Sub Sessions

Event

Can Israel Become the Next Biotech Start-Up Nation?

9:00 AM–9:45 AM on Tuesday, Apr 23, 2013


Event

Engaging with Chicago Area Multinational Biopharma

9:00 AM–10:15 AM on Tuesday, Apr 23, 2013

Event

Canadian Financial Incentives Spur Research and Development

10:00 AM–10:45 AM on Tuesday, Apr 23, 2013

Event

Massive Health Care Consolidation and Its Impact on Biotech

10:30 AM–11:30 AM on Tuesday, Apr 23, 2013

Event

Money Ball: Winning Venture Strategies

10:30 AM–11:30 AM on Tuesday, Apr 23, 2013


Event

Russia’s Drug Development Outlook

10:30 AM–11:30 AM on Tuesday, Apr 23, 2013

Event

adVENTURES in Academic Partnering

10:30 AM–11:30 AM on Tuesday, Apr 23, 2013


Event

Government Initiatives in New Drug Development in South Korea

11:00 AM–11:45 AM on Tuesday, Apr 23, 2013

cisco_141171

Partnering in the Cloud - Can Pharma Drive Innovation through Big Data?

2:00 PM–3:30 PM on Tuesday, Apr 23, 2013


Event

Corporate Venture Capital in the AgTech Entrepreneurial Ecosystem

2:30 PM–3:30 PM on Tuesday, Apr 23, 2013


Event

Broad-Spectrum Antivirals: The “New” Holy Grail

3:45 PM–5:00 PM on Tuesday, Apr 23, 2013

Event

Emerging Markets Heads of Patent Offices Discussion

3:45 PM–5:00 PM on Tuesday, Apr 23, 2013

myBIO Chatter

Speakers (156)

contact_10100 Julian Adams Professor University of Michigan
contact_9675 Bernd Allekotte Partner Grünecker
contact_9783 Jeff Allen Executive Director Friends of Cancer Research
contact_8372 Dirceu Bras Aparecido Barbano Director Chairman of ANVISA National Health Surveillance Agency – ANVISA
contact_9714 Anjan Aralihalli Senior Director Shionogi
contact_7081 Mikel Arriola Peñalosa Federal Commisioner COFEPRIS
contact_6265 Christopher P. Austin, MD Director, National Center for Advancing Translational Sciences National Institutes of Health
contact_9629 Stephen Auten Partner Cozen O'Connor
contact_7265 Lee Babiss CSO, EVP of Discovery Innovation, CEO of X-Rx PPD, Inc
User Richard Barker Director CASMI
contact_9989 Marc Berger Vice President, Real World Data and Analytics Pfizer Inc.
User Michelle Berrey Chief Medical Officer Chimerix, Inc.
contact_9282 Peter Bigelow President Sporting Hill Associates, LLC
User Sally Bolmer Senior V. P., Development and Regulatory Affairs Human Genome Sciences, Inc.
User Luciana Borio Assistant Commissioner for Counterterrorism Policy FDA/OC/OCET
contact_8363 Marc Boutin Executive Vice President & Chief Operating Officer National Health Council
contact_9936 Barbara Bramble Senior Advisor, International Climate and Energy Program National Wildlife Federation
contact_10074 Øyvind Brekke Senior Advisor DNB Bank ASA
contact_9932 Scott Burwell Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LL
User Sarah Byrne-Quinn VP, Business Development & Strategy - Europe Baxter International Inc.
contact_9674 Paul Cantrell Assistant General Patent Counsel Eli Lilly and Company
contact_9885 Ruben G. Carbonell Director, Biomanufacturing Education and Training Center BTEC
contact_10196 Lon Cardon Senior Vice President Alternative Discovery and Development GlaxoSmithKline
contact_5148 Darren Carroll VP of Corporate Business Development Eli Lilly and Company
contact_9652 Neal Carter President and Founder Okanagan Specialty Fruits, Inc.
John Chickosky John Chickosky President & CEO Natrix Separations
User Eda Cindoğlu Director Republic of Turkey Ministry of Health
contact_9969 Kate Clemans Senior Director Crowell & Moring LLP
contact_9733 Douglas Cole General Partner Flagship Ventures
User Rena Conti Instructor of Health Economics and Policy University of Chicago
User Gabrielle Cosel Project Manager Pew Charitable Trusts
contact_4090 W. Mark Crowell Executive Director, UVa Innovation Associate VP for Research, University of Virginia
User Chi Van Dang Director, Abramson Cancer Center University of Pennsylvania
User Tom Daniel President of Research and Early Development Celgene
contact_3918 Ora Dar Head of Life Sciences Office of the Chief Science Israeli Ministry of Economy
contact_10071 Nissim Darvish Senior Managing Director Orbimed Advisors LLC
contact_9825 Bernard Davitian VP & Managing Director Bioventures Sanofi
contact_2177 Manisha A. Desai, Ph.D. Assistant General Patent Counsel Eli Lilly and Company
contact_9869 Natalie DiNicola Vice President, Sustainable Agriculture Partnerships Monsanto
contact_1883 Kenneth Dow Assistant Patent Counsel & VP, Patent Johnson & Johnson / Janssen Biotech, Inc
User Elizabeth Duvall Associate Director of Regulatory Affairs, CDER FDA
User Earl Dye Director, Technical Regulatory Policy Genentech, Inc
contact_9890 Marek Dziki Executive Director of the Biomed cluster Skolkovo Foundation
contact_9811 Alexander P. F. Ehlers Attorney, Specialist for Health Care Law Ehlers, Ehlers & Partner
contact_74 Andrew Emmett Director, Science & Regulatory Affairs Biotechnology Industry Organization
User Marcus Farbstein Director Genentech, Inc
flechtner_6_ Jessica Flechtner Vice President of Research Genocea Biosciences
User Kimberly Fleming Senior Manager, Product Security EMD Serono, Inc
Neal_Fowler_2011(D)small Neal Fowler CEO Liquidia
User Patrick Frey Director, Office of Planning and Analysis, CDER FDA
contact_9828 Hon. Arthur Gajarsa (Retired) Former Senior Judge U.S. Court of Appeals for the Federal Circuit
User Chris Garabedian President and Chief Executive Officer Sarepta Therapeutics
contact_9713 Peter Garrambone Principal Torreya Partners, LLC
contact_6700 Seth Ginsberg President Global Healthy Living Foundation
contact_9732 David Grayzel Managing Director Atlas Venture Development Corp.
contact_8502 Neal Gutterson President & CEO Mendel Biotechnology, Inc
User Rachel Hartford Regulatory Project Manager U.S. Food & Drug Administration
contact_9697 Matthias Heck Head of Brussels Office German Pharmaceutical Industry Association (BPI)
DSCF0455_Snapseed Lisa Herron-Olson Chief Operating Officer Syntiron
contact_9877 Ben Heywood Co-Founder and President PatientsLikeMe
User Kay Holcombe Senior Policy Advisor at Genzyme Corporation Genzyme Corporation
contact_8810 Douglas A. Holtzman Vice President, Discovery Takeda Pharmaceuticals International
contact_9611 Paul Howard Director, Center for Medical Progress Manhattan Institute
contact_9043 Jack Huttner President & CEO Huttner Strategies, LLC
contact_9635 Claude Jodoin Partner Fasken Martineau DuMoulin LLP
User Karen Jones VP and Global Head of PD Regulatory Oncology Genentech, Inc
contact_9865 Vijayaraghavan Kannan South Asia Coordinator Agricultural Biotechnology Support Project II
Kasimova_photo_s Elena Kasimova Investment and Strategy Director Theramab LLC
contact_9803 Peter Keller, M.Sci. Chief Business Officer Selecta Biosciences
User Kenneth Kelley CEO Paxvax
User George Kemble Chief Scientific Officer 3-V Biosciences
User David Kenyon, PhD Senior Director of Process Sciences Gallus BioPharmaceuticals
contact_9970 Atul Keshap Senior Official for Asia Pacific Economic Cooperation Bureau of East Asian and Pacific Affairs
User Hannah Kettler Program Office, Policy and Advocacy The Bill and Melinda Gates Foundation
User Rita Khanna, Ph.D., J.D. General Counsel Aeras
NadavHeadshot-9.12 Nadav Kidron CEO Oramed Pharmaceuticals Inc.
User Gayle Kirkpatrick DVP, Scientific Assessment & Tech Licensing Abbott
contact_9676 Michael Kirschner Assistant General Counsel Baxter International Inc.
contact_10192 Chris Knepler Investment Commissioner Australian Trade Commission (Austrade)
User Dmitry Kulish Executive Vice President Nanolek
contact_1612 Jeff Kushan Partner Sidley Austin LLP
contact_9870 Richard Leach President and CEO World Food Program USA
User Jonathan Leff Partner Deerfield Management
User Ronald Lennox Partner CHL Medical Partners
User Robyn Lim Senior Science Advisor Health Canada
contact_3221 Stephen Long Professor of Plant Biology and Crop Sciences University of Illinois at Urbana-Champaign
contact_9639 Roger Longman CEO Real Endpoints
User Astrid Ludin Commissioner, Department of Trade and Industry Companies & Intellectual Property Commission CIPC
User Jonathan MacQuitty Partner Abingworth
contact_10097 Didier Malherbe Vice President, Public Affairs UCB SA/NV
User Ramkumar Mandalam President & CEO Cellerant Therapeutics
User John Maraganore Chief Executive Officer Alnylam Pharmaceuticals, Inc
User Miguel Margáin González Director Instituto Mexicano de la Propiedad Industrial
User Andrea Masciale Vice President, Global Regulatory Policy & Intelligence Janssen Pharmaceutical Companies
Yaacov Michlin, Yissum CEO Yaacov Michlin CEO Yissum
contact_9722 Thomas Moore Director of Value, Access and Policy at Amgen EuropaBIO
contact_9814 Pulakesh Mukherjee Principal BASF Venture Capital America Inc.
contact_10162 Andrew Munk President & CEO MRM PROTEOMICS INC.
contact_9636 Shahrooz Nabavi Partner Fasken Martineau DuMoulin LLP
contact_8963 Alexander Natz Director General EUCOPE
contact_9816 C. David Nicholson Global Head R&D Bayer CropScience AG
User Oleg Nodelman Founder and Managing Director EcoR1 Capital
User David Noll Director, Governmental Affairs Bavarian Nordic A/S
contact_9815 Derek Norman Investment Director Syngenta Ventures
contact_8329 Amy O'Connor Director, Digital Government Affairs Eli Lilly and Company
contact_7297 Jeff Odum Director of Operations Integrated Product Services
User Michael Okoroafor Vice President of Global Packaging Innovation and Breakthrough Innovation H.J. Heinz Company
User Ken Oye Professor MIT
contact_4689 Menelas Pangalos, PhD Executive Vice President, Innovative Medicines AstraZeneca
User Antoinette Paone, MS, MBA Senior Director, Regulatory Affairs CMC Vertex Pharmaceuticals Incorporated
contact_6419 Art Pappas Managing Partner Pappas Ventures
contact_6419 Art Pappas Managing Partner Pappas Ventures
User Adelene Perkins President & Chief Executive Officer Infinity Pharmaceuticals, Inc.
contact_9797 Roger Pomerantz Worldwide Head of Licensing & Acquisitions, SVP Merck Research Laboratories
User David Pritchard President & CEO KaloBios Pharmaceuticals, Inc
contact_862 Dennis Purcell Senior Managing Director Aisling Capital LLC
Raab2010_UConn_Agrivida R. Michael Raab President Agrivida, Inc.
contact_9990 Gunaretnam Rajagopal VP & CIO, Research, Bioinformatics & External Innovation Janssen Pharmaceutical Companies of Johnson &Johns
contact_207 Anna Rath President & CEO NexSteppe
contact_8165 Peter Richardson Head of Biologicals European Medicines Agency
contact_8510 Melinda Richter Founder and CEO Prescience International
User Timothy Rodell President and Chief Executive Officer GlobeImmune, Inc
contact_9992 Yury Rozenman Head of Marketing, Global Commerce British Telecom Services
contact_3767 James Schaeffer Exec Dir, Worldwide Licensing & External Research Merck
User Josh Scheinfeld Managing Member Lincoln Park Capital, LLC
contact_9840 Uwe Schoenbeck Chief Scientific Officer, External R&D Innovation Pfizer Inc.
User Christopher Seaton Snr. VP Negotiations Bayer HealthCare
contact_9827 Anna Shadman, MSc. VP, Compound Development Team Leader Janssen Alzheimer Immunotherapy R&D LLC
User Darryl J. Sleep MD, FCS, Vice President Clinical Science and Early Development Takeda Global Research and Development
User Rebecca Stankiewicz-Gabel Senior Environmental Protection Specialist USDA-APHIS
contact_8846 David Steinberg Partner Puretech Ventures
contact_9948 Peter Stenico Head of Commercial Operations Western Europe, Sandoz European Generic Medicines Association
contact_9813 Clifford Stocks Chief Executive Officer Theraclone Sciences, Inc.
User David Talbot Director, International Government Affairs Eli Lilly and Company
foto Daniil Talyanskiy Chief Business Officer IBC Generium
User Tracey Thompson CEO Polybatics
contact_8203 Mary Till Legal Advisor United States Patent and Trademark Office
contact_9728 Ed Torres Managing Director Lilly Ventures
contact_8659 David Torstensson Senior Consultant Pugatch Consilium
contact_3333 Scott Uknes co- CEO AgBiome
contact_1250 Geeta Vemuri Senior Managing Director Baxter International Inc.
contact_8584 Scott Vitters General Manager, PlantBottle Packaging Innovation Platform The Coca-Cola Company
User Gerald Voss, PhD. Director, Diseases of the Developing World GlaxoSmithKline Vaccines
User Mike Ward Co-chair, APEC Regulatory Harmonization Steering Committee Health Canada
contact_5934 Seth Waxman Partner WilmerHale
contact_9802 Leslie Williams Director, Founder, CEO and President IMMUSANT, INC.
contact_8476 Scott Williams Senior Vice President Men's Health Network
contact_10191 Nicole Williamson Country Head – Australia LanzaTech
contact_9886 Mark Witcher, PhD Principal Consultant IPS
contact_8969 Yun-Ling Wong Program Officer The Bill & Melinda Gates Foundation
User Durhane Wong-Rieger, PhD Chair, International Alliance of Patients' Organizations Consumer Advocare Network
User Seth Yakatan Co-Founder Katan Associates
User Tadataka Yamada Chief Medical & Scientific Officer Takeda Pharmaceuticals International
contact_270 Barbara Yanni VP & Chief Licensing Officer Merck
User Donna Lee Yesner Partner Morgan, Lewis & Bockius
contact_10138 Chihiro Yokota Vice President, Licensing & Alliances Astellas

Moderators (47)

contact_9402 Michael Abrams Managing Partner Numerof & Associates, Inc.
contact_9892 Nate Bailey Vice President, Grassroots Enterprise EDELMAN
User Liisa Bayko Senior Biotechnology Analyst JMP Securities
contact_9222 Ben Bonifant Consultant Bonifant Insights Group
contact_9913 Alexis Borisy Partner Third Rock Ventures
contact_9864 Julie Borlaug Associate Director for External Relations Borlaug Institute for Intl Agriculture - Texas A&M
contact_8506 Jonathan Burbaum Program Director U.S. Department of Energy
contact_9104 Karen Century Director, Research Collaborations Mendel Biotechnology
최윤희_ Youn-Hee Choi, Ph.D. Research Fellow Korea Institute for Industrial Economics & Trade
contact_9723 Salvatore D'Acunto Head of Unit Food, Healthcare Industries, Biotechn European Commission
contact_8884 Joseph Damond Senior Vice President International Affairs Biotechnology Industry Organization
contact_9859 Iain Dukes Vice President, External Research & Development Amgen Inc.
contact_7083 Mark Elliot Executive Vice President U.S. Chamber of Commerce, Global IP Center
contact_74 Andrew Emmett Director, Science & Regulatory Affairs Biotechnology Industry Organization
portrait Susan Finston President Finston Consulting, LLC
contact_5935 Mark Fleming Partner WilmerHale
User Joel Grosser Associate Booz Allen Hamilton
User Janet Jenkins-Showalter Senior Regulatory Group Director Roche
User Michael King, Jr. Managing Director and Senior Biotechnology Analyst JMP Securities
contact_9971 Craig Kramer Vice President, International Global Government Affairs Johnson & Johnson
User Marc LaForce Director, Technical Services Serum Institute of India, Ltd.
User Alan Liss Director, MCMi PHSAT Food And Drug Administration (FDA)
Doug-MacDougall_formal_cropped_300dpi Douglas MacDougall President MacDougall Biomedical Communications
contact_4840 Joel Marcus Chief Executive Officer Alexandria Real Estate Equities, Inc
contact_4840 Joel Marcus Chief Executive Officer Alexandria Real Estate Equities, Inc
contact_9181 John Marquardt Attorney at Law Marquardt Law
contact_9389 Cynthia Mazareas Special Counsel WilmerHale
contact_7984 Ryan McBride Executive Editor, Life Sciences Group Fierce Markets
contact_4655 John Mendlein, Ph.D. Executive Chairman and CEO aTyr Pharma, Inc.
User Chris Morrison Editor-in-Chief, Biopharmaceuticals and Consumer P Elsevier Business Intelligence
User Asher Mullard Senior News Editor Nature Reviews Drug Discovery
contact_8963 Alexander Natz Director General EUCOPE
contact_9414 Matthew Nielsen Partner Marshall, Gerstein & Borun LLP
Nizet Victor Nizet Professor of Pediatrics and Pharmacy University of California, San Diego
contact_4833 Rita Numerof President Numerof & Associates, Inc.
contact_9256 Mark Penner Partner Fasken Martineau DuMoulin LLP
contact_9889 Daniel M. Price Managing Director Rock Creek Global Advisors, LLC
User Jayson Punwani Associate Pappas Ventures
Tom Ranshohoff 67648 WEB - Headshot Thomas Ransohoff Vice President and Senior Consultant BioProcess Technology Consultants
contact_10135 Mikhail Samsonov Chief Medical Officer R-Pharm CJSC
contact_4544 Niranjan Sardesai Chief Operating Officer Inovio Pharmaceuticals, Inc
contact_9918 Dan Shoenholz Partner/Principal, Commercial Advisory Services Ernst & Young
contact_9930 Andrew Skibo Executive Vice President, Operations MedImmune
Smolinski MLA photo Ipsita Smolinski President Capitol Street
logo Daniel Teper CEO IMMUNE Pharmaceuticals
User Thomas Unger Executive Director Pfizer Inc.
contact_8371 Jorge Ávila President National Institute of Industrial Property

Who's Attending (1)

See all